» Articles » PMID: 16366591

Human P2Y(6) Receptor: Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference

Overview
Journal J Med Chem
Specialty Chemistry
Date 2005 Dec 22
PMID 16366591
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.

Citing Articles

Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y.

Zimmermann A, Vu O, Bruser A, Sliwoski G, Marnett L, Meiler J ChemMedChem. 2022; 17(7):e202100683.

PMID: 35034430 PMC: 9305961. DOI: 10.1002/cmdc.202100683.


A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Jacob T, Singh V, Dixit M, Ginsburg-Shmuel T, Fonseca B, Pintor J Purinergic Signal. 2018; 14(3):271-284.

PMID: 30019187 PMC: 6107468. DOI: 10.1007/s11302-018-9614-7.


Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y Receptor Agonists.

Toti K, Jain S, Ciancetta A, Balasubramanian R, Chakraborty S, Surujdin R Medchemcomm. 2018; 8(10):1897-1908.

PMID: 29423136 PMC: 5798474. DOI: 10.1039/C7MD00397H.


Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.

Gendaszewska-Darmach E, Szustak M Purinergic Signal. 2016; 12(2):199-209.

PMID: 26746211 PMC: 4854834. DOI: 10.1007/s11302-015-9492-1.


4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y receptor.

Jayasekara P, Barrett M, Ball C, Brown K, Kozma E, Costanzi S Medchemcomm. 2015; 4:1156-1165.

PMID: 26161252 PMC: 4493932. DOI: 10.1039/C3MD00132F.


References
1.
Jacobson K, Ji X, Li A, Melman N, Siddiqui M, Shin K . Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J Med Chem. 2000; 43(11):2196-203. PMC: 3471159. DOI: 10.1021/jm9905965. View

2.
Kim H, Ravi R, Marquez V, Maddileti S, Wihlborg A, Erlinge D . Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. J Med Chem. 2002; 45(1):208-18. PMC: 4957029. DOI: 10.1021/jm010369e. View

3.
Boyer J, Adams M, Ravi R, Jacobson K, Harden T . 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Br J Pharmacol. 2002; 135(8):2004-10. PMC: 1573330. DOI: 10.1038/sj.bjp.0704673. View

4.
Ohno M, Costanzi S, Kim H, Kempeneers V, Vastmans K, Herdewijn P . Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors. Bioorg Med Chem. 2004; 12(21):5619-30. PMC: 3402881. DOI: 10.1016/j.bmc.2004.07.067. View

5.
Costanzi S, Mamedova L, Gao Z, Jacobson K . Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem. 2004; 47(22):5393-404. PMC: 3431558. DOI: 10.1021/jm049914c. View